These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38810408)

  • 1. Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?
    Yaman S; Bozan E; Seçilmiş S; Candır BA; Kılınç A; Başcı S; Yiğenoğlu TN; Çakar MK; Dal MS; Altuntaş F
    Transfus Apher Sci; 2024 Aug; 63(4):103956. PubMed ID: 38810408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
    van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
    J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
    Shahzad M; Amin MK; Bellman P; Al-Ramahi J; Noor J; Vyas A; Mahmoudjafari Z; McGuirk M; DeJarnette S; Ahmed N; Abdallah AO; Shune L; Singh AK; McGuirk JP; Abhyankar S; Mushtaq MU
    Transfusion; 2024 Aug; 64(8):1402-1406. PubMed ID: 38847196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
    Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.
    Zhang C; Chen XH; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Gong Y; Zeng DF; Wang QY
    Transfus Med; 2010 Jun; 20(3):169-77. PubMed ID: 20136781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
    Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
    Liang ZY; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors.
    Kayser S; Schlenk RF; Steiner M; Klüter H; Wuchter P
    Transfus Med Hemother; 2023 Oct; 50(5):396-402. PubMed ID: 37899994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
    Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center.
    Bailén R; Pérez-Corral AM; Pascual C; Kwon M; Serrano D; Gayoso J; Balsalobre P; Muñoz C; Díez-Martín JL; Anguita J
    J Clin Apher; 2019 Aug; 34(4):373-380. PubMed ID: 30694583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience.
    Ozen M; Gunduz M; Topcuoglu P; Toprak SK; Dalva K; Gurman G; Ilhan O
    J Clin Apher; 2017 Feb; 32(1):16-20. PubMed ID: 26958783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation.
    Chanswangphuwana C; Kupatawintu P; Panjai P; Tunsittipun P; Intragumtornchai T; Bunworasate U
    Int J Hematol; 2014 Mar; 99(3):318-22. PubMed ID: 24474639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?
    Lysák D; Kořístek Z; Gašová Z; Skoumalová I; Jindra P
    J Clin Apher; 2011; 26(1):9-16. PubMed ID: 21312254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization?
    Piccirillo N; Putzulu R; Metafuni E; Massini G; Fatone F; Corbingi A; Giammarco S; Limongiello MA; Di Giovanni A; Zini G; Bacigalupo A; Teofili L; Sica S; Chiusolo P
    Transfus Med Rev; 2023 Apr; 37(2):150725. PubMed ID: 37315997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.